Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI

Aimée R. Kreimer, Anil K. Chaturvedi, Laia Alemany, Devasena Anantharaman, Freddie Bray, Mary Carrington, John Doorbar, Gypsyamber D'Souza, Carole Fakhry, Robert L. Ferris, Maura Gillison, D. Neil Hayes, Allan Hildesheim, Shao Hui Huang, Luiz P. Kowalski, Krystle A. Lang Kuhs, James Lewis, Douglas R. Lowy, Hisham Mehanna, Andy NessMichael Pawlita, Maisa Pinheiro, John Schiller, Meredith S. Shiels, Joseph Tota, Lisa Mirabello, Saman Warnakulasuriya, Tim Waterboer, William Westra, Stephen Chanock, Paul Brennan

Research output: Contribution to journalShort surveypeer-review

Abstract

Cancer of the oropharynx has attracted considerable attention in recent years given: (1) an increasing incidence in selected populations over the past three decades; (2) the discovery of human papillomavirus (HPV) infection as the driver of the increase, as opposed to the traditional risk factors such as tobacco (smoking and chewing) and alcohol; and (3) the promise of new prevention and treatment strategies. As a result of such developments, the International Agency for Research on Cancer (IARC) and the US National Cancer Institute (NCI), convened the fourth Cancer Seminar meeting in November 2018 to focus on this topic. This report summarizes the proceedings: a review of recent science on the descriptive epidemiology, etiology, biology, genetics, early detection, pathology and treatment of HPV-positive oropharyngeal cancer, and the formulation of key research questions to be addressed.

Original languageEnglish (US)
Article number104736
JournalOral Oncology
Volume108
DOIs
StatePublished - Sep 2020

Keywords

  • Etiology
  • Genetics
  • HPV
  • Oropharynx cancer
  • Prevention
  • Screening
  • Therapy

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI'. Together they form a unique fingerprint.

Cite this